References
- Antonangelo L, Faria CS, Sales RK. Tuberculous pleural effusion: diagnosis & management. Expert R. Respir Med. 2019;8:747-759.
- Apostolidou E, Tsilioni I, Hatzoglou C, et al. Pleural transport physiology: insights from biological marker measurements in transudates. Open Respir Med J. 2011;5:70–72.
- Gourgoulianis KI. Diagnostic value of adenosine deaminase activity in tuberculous effusions. Eur Respir J. 1990;3:1098.
- Skouras VS, Magkouta SF, Psallidas I, et al. Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence. Infect Dis (Auckl). 2015;47:477–483.
- Gerogianni I, Papala M, Tsopa P, et al. Could IFN-γ predict the development of residual pleural thickening in tuberculous pleurisy? Monaldi Arch Chest Dis. 2016;69:18–23.
- Kotsiou OS, Tzortzi P, Beta RAA, et al. Repeatability of pleural adenosine deaminase measurements in diagnostic evaluation of pleural effusions. J Clin Lab Anal. 2018;32:e22371.
- Daniil ZD, Zintzaras E, Kiropoulos T, et al. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J. 2007;30:957–964.
- World Health Organization (WHO). Tuberculosis country profiles. WHO; 2019c. [updated 2019 Jul 17]. Available from: https://www.who.int/tb/country/data/profiles/en/